Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Jan '25 Jan 23, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2019 - 2015
Market Capitalization	1,991	1,797	2,360	3,139	4,821	3,406	Upgrade
Market Cap Growth	-23.88%	-23.88%	-24.82%	-34.88%	41.53%	56.00%	Upgrade
Enterprise Value	2,138	1,818	2,294	2,857	4,456	3,200	Upgrade
Last Close Price	16.00	14.30	22.39	29.48	46.19	27.13	Upgrade
PS Ratio	678.12	678.12	11.96	14.38	47.07	50.06	Upgrade
PB Ratio	12.60	12.60	10.03	8.36	15.92	9.54	Upgrade
P/TBV Ratio	13.61	13.61	11.03	9.05	16.47	9.87	Upgrade
P/FCF Ratio	-	-	-	-	44.05	-	Upgrade
P/OCF Ratio	-	-	-	-	37.99	-	Upgrade
EV/Sales Ratio	686.02	686.02	11.63	13.09	43.51	47.03	Upgrade
EV/FCF Ratio	-4.74	-	-	-	40.72	-	Upgrade
Debt / Equity Ratio	4.46	4.46	1.34	0.19	0.06	0.05	Upgrade
Debt / FCF Ratio	-	-	-	-	0.17	-	Upgrade
Asset Turnover	0.00	0.00	0.33	0.35	0.22	0.20	Upgrade
Quick Ratio	6.57	6.57	3.75	2.67	2.58	7.78	Upgrade
Current Ratio	6.74	6.74	3.95	2.92	2.62	7.92	Upgrade
Return on Equity (ROE)	-254.98%	-254.98%	-59.33%	-42.67%	-32.36%	-23.96%	Upgrade
Return on Assets (ROA)	-39.43%	-39.43%	-17.58%	-15.91%	-15.11%	-13.35%	Upgrade
Return on Capital (ROIC)	-43.85%	-43.85%	-21.89%	-23.88%	-20.31%	-16.02%	Upgrade
Earnings Yield	-22.46%	-24.90%	-7.13%	-5.03%	-2.16%	-1.92%	Upgrade
FCF Yield	-22.64%	-25.10%	-11.48%	-5.40%	2.27%	-2.45%	Upgrade
Buyback Yield / Dilution	-12.21%	-12.21%	-1.26%	-1.62%	-3.00%	-2.14%	Upgrade
Total Shareholder Return	-12.21%	-12.21%	-1.26%	-1.62%	-3.00%	-2.14%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.